News Conference News HFSA 2025 Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74 Yael L. Maxwell September 30, 2025
News Conference News HFSA 2025 Voice Analysis Picks Up Patients at Risk for HF Hospitalization: COMMUNITY-HF Yael L. Maxwell September 29, 2025
News Conference News HRS 2025 Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe Todd Neale April 28, 2025
News Conference News AHA 2024 Nasal Bumetanide Safe, Effective in Healthy Adults Yael L. Maxwell November 18, 2024
News Conference News AHA 2024 Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F Michael O'Riordan November 16, 2024
News Conference News ESC Heart Failure 2024 Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients Michael O'Riordan May 13, 2024
News Conference News PCR London Valves 2023 Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway? Shelley Wood November 20, 2023
News Conference News AHA 2023 Large Study Affirms Safety of Pulsed-Field Ablation, Reveals Some Rare Complications Todd Neale November 13, 2023
News Conference News ESC 2023 Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF Todd Neale September 01, 2023
News Conference News ESC 2023 IV Iron in HF Misses (Again) in HEART-FID, but Meta-analysis Sees a Role Shelley Wood August 26, 2023
News Conference News ESC Heart Failure 2023 More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF Shelley Wood May 22, 2023
News Conference News AHA 2022 New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events Yael L. Maxwell November 07, 2022
News Conference News ESC 2022 Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR L.A. McKeown August 27, 2022
News Conference News ESC Heart Failure 2022 Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF Shelley Wood May 26, 2022
News Conference News ESC Heart Failure 2022 Speech-Recognition Tool May Predict Worsening Congestion in HF Shelley Wood May 22, 2022
News Conference News ACC 2022 QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis L.A. McKeown April 07, 2022
News Conference News THT 2022 Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality Caitlin E. Cox February 07, 2022
News Conference News AHA 2021 Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE Shelley Wood November 14, 2021
News Conference News ESC 2021 STEP Trial Supports Lower BP Goal in Older Patients With Hypertension Todd Neale August 30, 2021
News Conference News ACC 2021 REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay Caitlin E. Cox May 16, 2021